NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Valinor Discovery

Valinor Discovery

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://valinordiscovery.com/

Last Round

Seed

Dec 11, 2025

Total Funding Raised

$13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Valinor Discovery is a biotechnology company that provides an AI-powered platform to simulate drug responses before clinical trials using generative machine learning and patient-matched, longitudinal multi-omics data.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

drug discoverymulti-omicsAI drug discoveryfoundation modelsvirtual patientprecision medicinebiotech AIin silico drug discoverymachine learning platformtherapeutic targetsbiological researchclinical trial datagenerative biologybiopharma analyticspredictive modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valinor Discovery Comps

Public and private peers based on sector, stage, and business model.

Valinor Discovery comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Valinor Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025

Key People

Founding team and executive leadership

Joshua Pacini

CEO Co-Founder

Founding Team

Valinor Discovery Investors

Notable investors and investment history

Valinor Discovery investors
InvestorRounds
Pelion Venture PartnersSeed
Amino CollectiveSeed
Pelion Venture PartnersSeed
Harpoon VenturesSeed
CRVSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 21% QoQ from 14 to 17 employees.

  • Mar 2, 2026

    Combines machine learning capabilities with clinical laboratory infrastructure for multi-omics data generation.

Valinor Discovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valinor Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valinor Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range21
Year Founded2025
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.